Illumina Gets FDA Clearance for BeadXpress

The FDA clearance positions the firm to enter the clinical molecular diagnostics market with the BeadXpress system, which was previously marketed for research use only.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories